0001140361-23-031959.txt : 20230628 0001140361-23-031959.hdr.sgml : 20230628 20230628170617 ACCESSION NUMBER: 0001140361-23-031959 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230622 FILED AS OF DATE: 20230628 DATE AS OF CHANGE: 20230628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAUM CHARLES M CENTRAL INDEX KEY: 0001579824 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41551 FILM NUMBER: 231053082 MAIL ADDRESS: STREET 1: C/O MIRATI THERAPEUTICS INC. STREET 2: 9393 TOWNE CENTRE DRIVE, STE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acrivon Therapeutics, Inc. CENTRAL INDEX KEY: 0001781174 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 825125532 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 ARSENAL WAY, SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-207-8979 MAIL ADDRESS: STREET 1: 480 ARSENAL WAY, SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 form4.xml X0407 4 2023-06-22 0001781174 Acrivon Therapeutics, Inc. ACRV 0001579824 BAUM CHARLES M C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 true false Stock Option (Right to Buy) 12.88 2023-06-22 4 A 0 32500 0 A 2033-06-21 Common Stock 32500 32500 D The shares subject to the option shall vest in 36 substantially equal monthly installments beginning on June 22, 2023 ("Vesting Commencement Date"), such that all shares are fully vested on the third anniversary of the Vesting Commencement Date, in each case subject to the Reporting Person's continuous service through each such vesting date. /s/ Rasmus Holm-Jorgensen, Attorney-in-Fact 2023-06-28